Works matching DE "TEMOZOLOMIDE"
Results: 1675
The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13757-1
- By:
- Publication type:
- Article
Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 191, doi. 10.3390/pharmaceutics17020191
- By:
- Publication type:
- Article
Anti-Proliferative Activity of Ethylenediurea Derivatives with Alkyl and Oxygen-Containing Groups as Substituents.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 316, doi. 10.3390/biomedicines13020316
- By:
- Publication type:
- Article
An open‐label dose escalation study evaluating tolerability and safety of a single 5‐days course of temozolomide in dogs with advanced cancer.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 838, doi. 10.1111/vco.12623
- By:
- Publication type:
- Article
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 194, doi. 10.1111/vco.12335
- By:
- Publication type:
- Article
Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 90, doi. 10.1111/vco.12316
- By:
- Publication type:
- Article
Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 4, p. e146, doi. 10.1111/vco.12122
- By:
- Publication type:
- Article
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.
- Published in:
- Histochemistry & Cell Biology, 2018, v. 149, n. 3, p. 219, doi. 10.1007/s00418-018-1633-5
- By:
- Publication type:
- Article
Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors.
- Published in:
- Clinical Oral Investigations, 2015, v. 19, n. 1, p. 127, doi. 10.1007/s00784-014-1211-8
- By:
- Publication type:
- Article
Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion and TP53 mutation: a case report.
- Published in:
- Acta Neurochirurgica, 2020, v. 162, n. 12, p. 3019, doi. 10.1007/s00701-020-04514-3
- By:
- Publication type:
- Article
Reversed-Phase HPLC Method for Determination of Temozolomide in Rat Plasma and Brain: Simple, Sensitive and Robust Method.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 52, n. 3, p. 266, doi. 10.1007/s11094-018-1804-7
- By:
- Publication type:
- Article
Improved Method for Isolating Temozolomide from its Dimethylsulfoxide Solvate.
- Published in:
- Pharmaceutical Chemistry Journal, 2014, v. 48, n. 6, p. 398, doi. 10.1007/s11094-014-1119-2
- By:
- Publication type:
- Article
ONC201 for Glioma Treatment: Adding an Important Weapon to Our Arsenal.
- Published in:
- Neuroglia, 2023, v. 4, n. 1, p. 28, doi. 10.3390/neuroglia4010003
- By:
- Publication type:
- Article
Diagnostic Significance of Pre-Treatment Prognostic Nutritional Index, Platelet/Albumin Ratio and Red Cell Distribution Width in Patients with Differentiated Glioblastoma from Brain Metastasis.
- Published in:
- Eurasian Journal of Medical Investigation, 2023, v. 7, n. 4, p. 426, doi. 10.14744/ejmi.2023.42052
- By:
- Publication type:
- Article
Pediatric glioblastoma treated with concurrent radiotherapy and adjuvant Temozolomide: A case study of the treatment of pediatric GBM by the technique of volumetric modulated arc therapy.
- Published in:
- Radiološke Tehnologije, 2021, v. 12, n. 1, p. 38, doi. 10.48026/issn.26373297.2021.12.1.4
- By:
- Publication type:
- Article
Adjuvant Temozolomide Therapy Tolerance in Geriatric Glioblastoma Multiforme Patients.
- Published in:
- European Journal of Geriatrics & Gerontology, 2024, v. 6, n. 3, p. 165, doi. 10.4274/ejgg.galenos.2024.2024-4-2
- By:
- Publication type:
- Article
Glioblastoma Break-in; Try Something New.
- Published in:
- International Journal of Cancer Management, 2021, v. 14, n. 1, p. 1, doi. 10.5812/ijcm.109054
- By:
- Publication type:
- Article
Clinical Experience with Glioblastoma Multiforme in Pediatric Patients.
- Published in:
- International Journal of Cancer Management, 2017, v. 10, n. 12, p. 1, doi. 10.5812/ijcm.8100
- By:
- Publication type:
- Article
EGFR Amplified and Overexpressing Glioblastomas and Association With Better Response to Adjuvant Metronomic Temozolomide.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv041
- By:
- Publication type:
- Article
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju370
- By:
- Publication type:
- Article
Disposable Nanosensor for the Electrochemical Determination of Temozolomide and İts Interaction with Double-Stranded DNA.
- Published in:
- Analytical Letters, 2024, v. 57, n. 11, p. 1727, doi. 10.1080/00032719.2023.2267704
- By:
- Publication type:
- Article
Covalent functionalization of hybrid multi-walled carbon nanotube-graphene with polyethileneglycol for targeted delivery of Temozolomide.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 303, doi. 10.33320/10.33320/maced.pharm.bull.2022.68.03.146
- By:
- Publication type:
- Article
Effect of irradiation on the physicochemical and biopharmaceutical properties of Temozolomide loaded carbon nanotubes.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2020, v. 66, p. 115, doi. 10.33320/maced.pharm.bull.2020.66.03.057
- By:
- Publication type:
- Article
Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide.
- Published in:
- Journal of Immunology Research, 2022, p. 1, doi. 10.1155/2022/1346094
- By:
- Publication type:
- Article
Phase 3 Evidence for New Standard in Elderly Glioblastoma Patients.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 6, p. 261
- Publication type:
- Article
Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5579359
- By:
- Publication type:
- Article
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-85339-x
- By:
- Publication type:
- Article
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68801-0
- By:
- Publication type:
- Article
GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68626-x
- By:
- Publication type:
- Article
Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65398-2
- By:
- Publication type:
- Article
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1499, doi. 10.3390/biom13101499
- By:
- Publication type:
- Article
Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma Cells.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1408, doi. 10.3390/biom13091408
- By:
- Publication type:
- Article
Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 10, p. N.PAG, doi. 10.3390/biom12101379
- By:
- Publication type:
- Article
The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 7, p. 1015, doi. 10.3390/biom10071015
- By:
- Publication type:
- Article
Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00134
- By:
- Publication type:
- Article
Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca<sup>2+</sup>]<sub>i</sub>-dependent Activation of Na,K-ATPase/ERK<sub>1/2</sub> Signaling.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00873
- By:
- Publication type:
- Article
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00874
- By:
- Publication type:
- Article
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01568
- By:
- Publication type:
- Article
Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01416
- By:
- Publication type:
- Article
Cost-Effectiveness of [<sup>18</sup>F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00814
- By:
- Publication type:
- Article
C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00485
- By:
- Publication type:
- Article
Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00463
- By:
- Publication type:
- Article
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00186
- By:
- Publication type:
- Article
Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00041
- By:
- Publication type:
- Article
Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00033
- By:
- Publication type:
- Article
Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole‐trimethoprim and temozolomide.
- Published in:
- Nephrology, 2021, v. 26, n. 1, p. 12, doi. 10.1111/nep.13783
- By:
- Publication type:
- Article
Enhanced Anticancer Effect of Temozolomide through Synergistic Combination with Diltiazem in Neuroblastoma (SH-SY5Y) Cell Line.
- Published in:
- Cumhuriyet Medical Journal, 2023, v. 45, n. 2, p. 46, doi. 10.7197/cmj.1313269
- By:
- Publication type:
- Article
A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic Treatments.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 12, p. 1201, doi. 10.1007/s40273-014-0198-y
- By:
- Publication type:
- Article
LncRNA‐associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastoma.
- Published in:
- Journal of Molecular Recognition, 2023, v. 36, n. 12, p. 1, doi. 10.1002/jmr.3060
- By:
- Publication type:
- Article
Experimental Validation and Multi-omics Analysis Identified ARPC1A as a Novel Oncogene and Potential Therapeutic Target in Glioblastoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 12, p. 3958, doi. 10.7150/jca.94552
- By:
- Publication type:
- Article